DIA
Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Add Filter

    Advanced Search

    Find Meetings & Training 

    Name Start Date Credits Format Region Location
    Generic Drug Labeling Proposed Rule and Safety Updates Feb 02, 2015 Online Instruction Global Online
    Emerging Technologies to Rare Disorder Drug Development: Promises and Pitfalls Feb 02, 2015 Online Instruction Global Online
    Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Feb 02, 2015 Online Instruction Global Online
    Implementation of the FDASIA Patient Provisions Feb 02, 2015 Online Instruction Global Online
    Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Feb 02, 2015 Online Instruction Global Online
    Variations in the European Union: CMC/Quality Changes Feb 02, 2015 Online Instruction Global Online
    Proarrhythmia Feb 02, 2015 Online Instruction Global Online
    Facets of Drug-Induced Kidney Injury and Regulatory Perspective Feb 02, 2015 Online Instruction Global Online
    Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Feb 02, 2015 Online Instruction Global Online
    Pharmacovigilance and Risk Management: Patient Perspective Feb 02, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Feb 02, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Feb 02, 2015 Online Instruction Global Online
    Pharmacovigilance and Global Harmonization Updates Feb 02, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Feb 02, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Feb 02, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Feb 02, 2015 Online Instruction Global Online
    Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Feb 02, 2015 Online Instruction Global Online
    Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Feb 02, 2015 Online Instruction Global Online
    Introductory Principles and Application of Risk Management within Clinical Operations Feb 02, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Feb 02, 2015 Online Instruction Global Online
    Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Feb 02, 2015 Online Instruction Global Online
    Disruptive Innovation in Medical Information Feb 02, 2015 Online Instruction Global Online
    Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Feb 02, 2015 Online Instruction Global Online
    Implementing Risk-Based Monitoring: Practical Approaches Feb 02, 2015 Online Instruction Global Online
    Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Feb 02, 2015 Online Instruction Global Online
    Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Feb 02, 2015 Online Instruction Global Online
    Pricing, Economic, Reimbursement, Market Share (PERMS) Strategy: An Interactive Holistic Approach in Rare Diseases Feb 02, 2015 Online Instruction Global Online
    How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Feb 02, 2015 Online Instruction Global Online
    Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Feb 02, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Feb 02, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Feb 02, 2015 Online Instruction Global Online
    Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Feb 02, 2015 Online Instruction Global Online
    Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Feb 02, 2015 Online Instruction Global Online
    The Future of Personalized Medicine and Companion Diagnostics Feb 02, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Feb 02, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Feb 02, 2015 Online Instruction Global Online
    Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Feb 02, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Feb 02, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Feb 02, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Feb 02, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Feb 02, 2015 Online Instruction Global Online